vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.

READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $38.9M, roughly 1.3× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -5.1%, a 29.8% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -14.2%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $4.1M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 5.6%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.

CDXS vs RDI — Head-to-Head

Bigger by revenue
RDI
RDI
1.3× larger
RDI
$50.3M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+95.5% gap
CDXS
81.3%
-14.2%
RDI
Higher net margin
CDXS
CDXS
29.8% more per $
CDXS
24.7%
-5.1%
RDI
More free cash flow
CDXS
CDXS
$15.5M more FCF
CDXS
$19.6M
$4.1M
RDI
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
5.6%
RDI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
RDI
RDI
Revenue
$38.9M
$50.3M
Net Profit
$9.6M
$-2.6M
Gross Margin
94.8%
Operating Margin
27.1%
-1.9%
Net Margin
24.7%
-5.1%
Revenue YoY
81.3%
-14.2%
Net Profit YoY
192.5%
-14.5%
EPS (diluted)
$0.13
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
RDI
RDI
Q4 25
$38.9M
$50.3M
Q3 25
$8.6M
$52.2M
Q2 25
$15.3M
$60.4M
Q1 25
$7.5M
$40.2M
Q4 24
$21.5M
$58.6M
Q3 24
$12.8M
$60.1M
Q2 24
$8.0M
$46.8M
Q1 24
$17.1M
$45.1M
Net Profit
CDXS
CDXS
RDI
RDI
Q4 25
$9.6M
$-2.6M
Q3 25
$-19.6M
$-4.2M
Q2 25
$-13.3M
$-2.7M
Q1 25
$-20.7M
$-4.8M
Q4 24
$-10.4M
$-2.2M
Q3 24
$-20.6M
$-7.0M
Q2 24
$-22.8M
$-12.8M
Q1 24
$-11.5M
$-13.2M
Gross Margin
CDXS
CDXS
RDI
RDI
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
RDI
RDI
Q4 25
27.1%
-1.9%
Q3 25
-220.3%
-0.6%
Q2 25
-83.9%
4.8%
Q1 25
-271.6%
-17.2%
Q4 24
-34.2%
2.6%
Q3 24
-129.0%
-0.6%
Q2 24
-284.9%
-16.4%
Q1 24
-69.6%
-16.7%
Net Margin
CDXS
CDXS
RDI
RDI
Q4 25
24.7%
-5.1%
Q3 25
-228.1%
-8.0%
Q2 25
-86.6%
-4.4%
Q1 25
-274.3%
-11.8%
Q4 24
-48.4%
-3.8%
Q3 24
-160.8%
-11.7%
Q2 24
-285.2%
-27.4%
Q1 24
-67.4%
-29.4%
EPS (diluted)
CDXS
CDXS
RDI
RDI
Q4 25
$0.13
$-0.11
Q3 25
$-0.22
$-0.18
Q2 25
$-0.16
$-0.12
Q1 25
$-0.25
$-0.21
Q4 24
$-0.12
$-0.11
Q3 24
$-0.29
$-0.31
Q2 24
$-0.32
$-0.57
Q1 24
$-0.16
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
RDI
RDI
Cash + ST InvestmentsLiquidity on hand
$78.2M
$10.5M
Total DebtLower is stronger
$40.1M
$185.1M
Stockholders' EquityBook value
$50.5M
$-18.2M
Total Assets
$147.8M
$434.9M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
RDI
RDI
Q4 25
$78.2M
$10.5M
Q3 25
$58.7M
$8.1M
Q2 25
$66.3M
$9.1M
Q1 25
$59.8M
$5.9M
Q4 24
$73.5M
$12.4M
Q3 24
$90.3M
$10.1M
Q2 24
$73.2M
$9.3M
Q1 24
$85.5M
$7.5M
Total Debt
CDXS
CDXS
RDI
RDI
Q4 25
$40.1M
$185.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
$202.7M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
RDI
RDI
Q4 25
$50.5M
$-18.2M
Q3 25
$38.5M
$-12.1M
Q2 25
$55.6M
$-7.7M
Q1 25
$49.6M
$-8.1M
Q4 24
$66.9M
$-4.4M
Q3 24
$73.4M
$1.6M
Q2 24
$61.4M
$6.5M
Q1 24
$79.3M
$18.0M
Total Assets
CDXS
CDXS
RDI
RDI
Q4 25
$147.8M
$434.9M
Q3 25
$124.0M
$435.2M
Q2 25
$138.2M
$438.1M
Q1 25
$128.9M
$441.0M
Q4 24
$149.0M
$471.0M
Q3 24
$148.2M
$495.7M
Q2 24
$132.0M
$494.9M
Q1 24
$149.6M
$494.9M
Debt / Equity
CDXS
CDXS
RDI
RDI
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
RDI
RDI
Operating Cash FlowLast quarter
$20.1M
$4.3M
Free Cash FlowOCF − Capex
$19.6M
$4.1M
FCF MarginFCF / Revenue
50.3%
8.2%
Capex IntensityCapex / Revenue
1.3%
0.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$-2.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
RDI
RDI
Q4 25
$20.1M
$4.3M
Q3 25
$-7.7M
$295.0K
Q2 25
$-18.0M
$1.6M
Q1 25
$-13.8M
$-7.7M
Q4 24
$-16.5M
$8.0M
Q3 24
$-13.0M
$1.3M
Q2 24
$-12.2M
$-10.4M
Q1 24
$-7.8M
$-2.8M
Free Cash Flow
CDXS
CDXS
RDI
RDI
Q4 25
$19.6M
$4.1M
Q3 25
$-7.9M
$-246.0K
Q2 25
$-20.5M
$1.2M
Q1 25
$-15.1M
$-8.0M
Q4 24
$-18.2M
$7.0M
Q3 24
$-14.0M
$-1.1M
Q2 24
$-12.6M
$-10.6M
Q1 24
$-8.9M
$-4.7M
FCF Margin
CDXS
CDXS
RDI
RDI
Q4 25
50.3%
8.2%
Q3 25
-91.7%
-0.5%
Q2 25
-133.6%
1.9%
Q1 25
-199.6%
-19.8%
Q4 24
-85.0%
12.0%
Q3 24
-109.0%
-1.8%
Q2 24
-157.5%
-22.7%
Q1 24
-52.2%
-10.4%
Capex Intensity
CDXS
CDXS
RDI
RDI
Q4 25
1.3%
0.3%
Q3 25
2.1%
1.0%
Q2 25
16.4%
0.6%
Q1 25
16.7%
0.6%
Q4 24
8.3%
1.7%
Q3 24
7.8%
4.0%
Q2 24
5.0%
0.5%
Q1 24
6.6%
4.3%
Cash Conversion
CDXS
CDXS
RDI
RDI
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

RDI
RDI

Cinema Exhibition Segment$46.9M93%
Real Estate Revenue$3.4M7%

Related Comparisons